JR14a
Crovalimab (Anti-Complement C5)
Lendalizumab (Anti-Complement C5)
Compstatin
Phaseoloidin
3-Phenoxybenzaldehyde
C1s-IN-1
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Crovalimab
Olendalizumab
Pozelimab
Pexelizumab
Gavilimomab
Gefurulimab
Avdoralimab
Vilobelimab
Lampalizumab
Vesencumab
Tesidolumab
Ravulizumab